Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery
Cardiac diseases are the leading cause of deaths worldwide; however, to date, there has been limited progress in the development of therapeutic options for these conditions. Animal models have been the most extensively studied methods to recapitulate a wide variety of cardiac diseases, but these mod...
Main Authors: | Juan Huang, Qi Feng, Li Wang, Bingying Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.655161/full |
Similar Items
-
Human Pluripotent Stem-Cell-Derived Models as a Missing Link in Drug Discovery and Development
by: Xiying Lin, et al.
Published: (2021-05-01) -
APLNR marks a cardiac progenitor derived with human induced pluripotent stem cells
by: Yin-Yu Lam, et al.
Published: (2023-07-01) -
Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege
by: Yi-Hsien Fang, et al.
Published: (2020-03-01) -
How induced pluripotent stem cells are informing drug discovery in psychiatry
by: Yishan Sun, et al.
Published: (2016-01-01) -
The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications
by: Amr A. Youssef, MD, PhD, et al.
Published: (2016-10-01)